Department of Orthopaedics and Traumatology, Samsun University, Samsun, Turkey.
Department of Orthopaedics and Traumatology, Ondokuz Mayıs University, Samsun, Turkey.
Clin Orthop Relat Res. 2023 Nov 1;481(11):2125-2136. doi: 10.1097/CORR.0000000000002709. Epub 2023 May 29.
Myxofibrosarcoma (MFS) is a spectrum of aggressive soft tissue fibroblastic neoplasms characterized by variable myxoid stroma, pleomorphism, and a distinctive curved vascular pattern; these tumors are associated with a high likelihood of recurrence. Better local tumor control (a tumor-free margin) is believed to be important to minimize the risk of recurrence, but the effect of surgical resection margin status on local recurrence and survival in MFS is not as well-characterized as it might be.
QUESTIONS/PURPOSES: (1) Is margin width associated with local recurrence? (2) Is there a relationship between greater margin thickness and improved overall and disease-free survival (DFS)? (3) Is worsening French Federation of Cancer Centers grade associated with local recurrence and poorer overall survival?
Using a database of patients with bone and soft tissue tumors at a tertiary university hospital, we retrospectively reviewed the medical records of 282 patients who had soft tissue sarcomas and who had been surgically treated by a multidisciplinary bone and soft tissue tumor care team between January 2010 and December 2021. Of these 282 patients, 38 were identified as having MFS. Patients who received surgical care for MFS outside our institution (unplanned resection) (four patients) and whose surgical margins were not reported as microscopic numerical data (10) were excluded from the analysis. We estimated survival and local recurrence and examined factors potentially influencing these outcomes. Patient demographics, tumor characteristics, surgical margin distance (in mm), and disease-related outcomes were recorded. The minimum follow-up was 3 months (median 41.5 months, range 3 to 128 months).
Overall 1-year local recurrence-free rates were 66.7% (95% CI 50% to 88%). Patients with positive margins were more likely to have local recurrence than patients with negative margins (HR 10.91 [95% CI 2.61 to 45.66]; p = 0.001). Patients with an inadequate margin (positive margin or a negative margin of 1 mm or less) had a greater risk of local recurrence (HR 9.96 [95% CI 1.22 to 81.44]; p = 0.032). Patients with positive margins or margins less than or equal to 1 mm had worse 2-year local recurrence-free survival than did those with margins of greater than 1 mm (46.9% [95% CI 16% to 76%] versus 91.7% [95% CI 75% to 100%]; p = 0.005). The mean overall survival was 98 months (95% CI 77.2 to 118.8). The Kaplan-Meier overall 1-, 2- and 5-year estimated rates of survival were 88% (95% CI 75% to 100%), 79.2% (95% CI 64.5% to 97.2%), and 73.5% (95% CI 57.2 % to 94.5%), respectively. Positive surgical margins were associated with decreased overall survival (HR 6.96 [95% CI 1.39 to 34.89]; p = 0.018). There was a mean DFS time of 4.25 months (95% CI 0.92 to 7.59) in microscopically positive patients, 75.5 months (95% CI 37.47 to 113.53) in patients with margins 1 mm or less, and 118 months (95% CI 99.23 to 136.77) in patients with margins over 1 mm. There was a statistical difference between DFS times according to surgical margin classification (p < 0.001). With the numbers we had, we could not detect any difference between the histologic grades determined by the French Federation of Cancer Centers grading system in terms of local recurrence (HR 3.80 [95% CI 0.76 to 18.94]; p = 0.103) and overall survival (HR 6.91 [95% CI 0.79 to 60.13]; p = 0.080). Tumor size was the prognostic factor associated with a higher local recurrence rate among all factors analyzed as univariate (HR 1.18 [95% CI 1.05 to 1.32]; p = 0.004).
A surgical procedure with a sufficient negative surgical margin distance appears to be associated with a lower proportion of patients who experience a local recurrence and is associated with overall patient survival. It is difficult to define what a sufficient margin is, but in our patients, it appears to be greater than 1 mm.Level of Evidence Level III, therapeutic study.
黏液纤维肉瘤(MFS)是一种具有可变黏液样基质、多形性和独特弯曲血管模式的侵袭性软组织成纤维细胞肿瘤谱;这些肿瘤与高复发率相关。更好的局部肿瘤控制(无肿瘤边缘)被认为是降低复发风险的重要因素,但手术切除边缘状态对 MFS 局部复发和生存的影响尚未得到充分描述。
问题/目的:(1) 边缘宽度与局部复发有关吗?(2) 边缘厚度较大是否与整体和无病生存率(DFS)提高有关?(3) 法国癌症中心分级恶化是否与局部复发和整体生存率降低有关?
我们使用三级大学医院骨与软组织肿瘤数据库,回顾性分析了 2010 年 1 月至 2021 年 12 月期间由多学科骨与软组织肿瘤护理团队手术治疗的 282 名软组织肉瘤患者的医疗记录。在这 282 名患者中,有 38 名被诊断为患有 MFS。在我们机构外接受 MFS 手术治疗(计划外切除)的患者(4 例)和手术边缘未报告为显微镜下数字数据(10 例)的患者被排除在分析之外。我们估计了生存和局部复发情况,并检查了可能影响这些结果的因素。记录了患者的人口统计学特征、肿瘤特征、手术边缘距离(mm)和疾病相关结局。最小随访时间为 3 个月(中位数 41.5 个月,范围 3 至 128 个月)。
整体 1 年局部无复发生存率为 66.7%(95%CI 50%至 88%)。与阴性边缘相比,阳性边缘患者发生局部复发的可能性更大(HR 10.91[95%CI 2.61 至 45.66];p=0.001)。边缘不足(阳性边缘或阴性边缘为 1mm 或更短)的患者发生局部复发的风险更高(HR 9.96[95%CI 1.22 至 81.44];p=0.032)。与边缘大于 1mm 的患者相比,边缘阳性或边缘等于或小于 1mm 的患者 2 年局部无复发生存率更差(46.9%[95%CI 16%至 76%]与 91.7%[95%CI 75%至 100%];p=0.005)。平均总生存期为 98 个月(95%CI 77.2 至 118.8)。Kaplan-Meier 总 1、2 和 5 年估计生存率分别为 88%(95%CI 75%至 100%)、79.2%(95%CI 64.5%至 97.2%)和 73.5%(95%CI 57.2%至 94.5%)。阳性手术边缘与总生存率降低相关(HR 6.96[95%CI 1.39 至 34.89];p=0.018)。在显微镜下阳性的患者中,DFS 时间的平均为 4.25 个月(95%CI 0.92 至 7.59),边缘为 1mm 或更短的患者为 75.5 个月(95%CI 37.47 至 113.53),边缘大于 1mm 的患者为 118 个月(95%CI 99.23 至 136.77)。根据手术边缘分类,DFS 时间存在统计学差异(p<0.001)。根据我们的病例数量,我们无法检测到法国癌症中心分级系统确定的组织学分级之间在局部复发(HR 3.80[95%CI 0.76 至 18.94];p=0.103)和整体生存率(HR 6.91[95%CI 0.79 至 60.13];p=0.080)方面的差异。在所有分析的因素中,肿瘤大小是与局部复发率较高相关的预后因素(HR 1.18[95%CI 1.05 至 1.32];p=0.004)。
具有足够负性手术边缘距离的手术程序似乎与较低的局部复发率相关,并与整体患者生存率相关。很难定义什么是足够的边缘,但在我们的患者中,它似乎大于 1mm。证据水平为 III 级,治疗研究。